Improving Metabolic(대사 개선)란 무엇입니까?
Improving Metabolic 대사 개선 - Main funding source(s): Guy"s and St Thomas" Charity University College London Hospital Biomedical Research Centre In people with obesity, bariatric surgery reduces mortality, heart failure and coronary disease, improving metabolic (blood sugar, lipid profile, inflammation) and cardiovascular (diastolic/systolic function, filling pressure, cardiac remodelling) parameters. [1] Osteocalcin is required for hydroxyapatite alignment, conferring bone structural integrity, decreasing fracture risk and improving metabolic/endocrine homeodynamics. [2] We evaluated serum uric acid concentration in relation to metabolic syndrome, as well as metabolically obese normal weight features, and examined its usefulness in improving metabolic and metabolically obese normal weight syndrome diagnosis in young people. [3] In this doctoral thesis, we present the results of a systematic review and a clinical study that demonstrates the impact of interventions with either resistance and/or multicomponent physical exercise programs in improving metabolic and inflammatory outcomes, thus preventing functional deterioration and improving cognitive status and quality of life in very elderly patients during acute hospitalization, in recognized JCR-indexed international scientific journals on the Web of Science - Journal Citation Reports. [4] To evaluate the efficacy and safety of colchicine for improving metabolic and inflammatory outcomes in people with obesity and metabolic syndrome (MetS). [5] As colchicine has been shown to prevent assembly of the NLRP3 inflammasome and ameliorate other inflammatory conditions, we aimed to evaluate the efficacy and safety of colchicine for improving metabolic and inflammatory outcomes in adults with obesity and MetS. [6] Therefore, the objective of this study was to assess the efficacy of endogenous microbial GABA production in improving metabolic and behavioural outcomes in a mouse model of metabolic dysfunction. [7]nan [1] nan [2] nan [3] nan [4] 비만 및 대사 증후군(MetS)이 있는 사람들의 대사 및 염증 결과를 개선하기 위한 콜히친의 효능 및 안전성을 평가합니다. [5] 콜히친은 NLRP3 인플라마솜의 조립을 방지하고 다른 염증 상태를 개선하는 것으로 나타났으므로 우리는 비만 및 MetS가 있는 성인의 대사 및 염증 결과를 개선하기 위한 콜히친의 효능과 안전성을 평가하는 것을 목표로 했습니다. [6] 따라서 이 연구의 목적은 대사 기능 장애의 마우스 모델에서 대사 및 행동 결과를 개선하는 데 내인성 미생물 GABA 생산의 효능을 평가하는 것이었습니다. [7]
Thereby Improving Metabolic 따라서 신진 대사를 개선
Decreasing PEA-15 expression increases the sequestering of lipids in adipose tissue, protecting other tissues in obesity, thereby improving metabolic health. [1] rhamnosus 86 could prevent obesity, thereby improving metabolic health. [2] Supplementation of rumen-protected choline (RPC) has attracted major research efforts during the last decade, assuming that choline improves liver function by increasing very low-density lipoprotein exportation from the liver, thereby improving metabolic profiles, milk production, and reproduction. [3] Reduction in the circulating levels of branched-chain amino acids through dietary supplementation with α-ketoglutarate to promote their transamination in the small intestine and other tissues can restore nitric oxide synthesis in the vasculature and reduce the weights of white adipose tissues, thereby improving metabolic profiles and whole-body insulin sensitivity (indicated by oral glucose tolerance test) in diet-induced obese rats. [4] These results indicate that GA suppresses adipocyte hypertrophy and inflammation caused by the interaction between adipocytes and macrophages, thereby improving metabolic disorders such as insulin resistance and dyslipidemia. [5]nan [1] nan [2] 반추위 보호 콜린(RPC)의 보충은 콜린이 간으로부터의 초저밀도 지단백질 배출을 증가시켜 간 기능을 향상시켜 신진대사 프로필, 우유 생산 및 번식을 개선한다는 가정하에 지난 10년 동안 주요 연구 노력을 끌어왔습니다. [3] 소장 및 기타 조직에서 아미노 전환을 촉진하기 위한 α-케토글루타레이트의 식이 보충제를 통한 분지쇄 아미노산의 순환 수준 감소는 혈관계에서 산화질소 합성을 회복하고 백색 지방 조직의 중량을 감소시켜 대사 프로파일을 개선할 수 있습니다 및 식이 유발 비만 쥐의 전신 인슐린 감수성(경구 내당능 시험에 의해 표시됨). [4] nan [5]
Also Improving Metabolic 또한 대사 개선
Background: Roux-en-Y gastric bypass (RYGB) surgery is one of the most efficient procedures for the treatment of obesity, also improving metabolic and inflammatory status, in patients with mild obesity. [1] Background Roux-en-Y gastric bypass (RYGB) surgery is one of the most efficient procedures for the treatment of obesity, also improving metabolic and inflammatory status, in patients with mild obesity. [2]improving metabolic health 대사 건강 개선
Our results suggest that 12 weeks of aerobic exercise training is effective in improving metabolic health, fat depots, ectopic fat and inflammation even against a high-fat dietary background. [1] Decreasing PEA-15 expression increases the sequestering of lipids in adipose tissue, protecting other tissues in obesity, thereby improving metabolic health. [2] Background Dietary sulfur amino acid (SAA) restriction is an established animal model for increasing lifespan and improving metabolic health. [3] Exercise is advocated for improving metabolic health, in part by increasing peripheral insulin sensitivity and glycaemic control. [4] What is the impact of a three-component lifestyle intervention on the prevalence and severity of metabolic syndrome (MetS) in women with polycystic ovary syndrome (PCOS)? This three-component lifestyle intervention was more successful in improving metabolic health in reproductive-aged women with PCOS compared to minimal treatment. [5] Restricted feeding (RF) is a dietary regimen aimed at improving metabolic health and extending longevity, as well as reorganizing sleep-wake cycles. [6] A better understanding of the adipocyte subtypes that compose different depots will help explain metabolic disease phenotypes associated with adipose tissue distribution and suggest new strategies for improving metabolic health. [7] rhamnosus 86 could prevent obesity, thereby improving metabolic health. [8] Replacing sitting time by standing and walking is an attractive alternative to moderate-to-vigorous exercise for improving metabolic health. [9] CONCLUSIONS The overall result found out in this synthesis was that the greater adherence to healthy eating patterns was considered a preventive to the transition from metabolically healthy obesity to metabolic unhealthy obese phenotypes, by improving metabolic health, and reducing the risk of cardiovascular disease and mortality from all causes. [10] TRFs have proven useful in improving metabolic health in adult subjects with obesity. [11] Aim A low‐carbohydrate, healthy‐fat (LCHF) dietary approach has been demonstrated as an effective strategy for improving metabolic health; however, it is often criticised for being more expensive than following a dietary approach guided by the national, Ministry of Health nutrition guidelines. [12] The emerging concept of white fat browning–conversion to beige/brown fat–has been controversial in its anti-obesity effect through facilitation of weight loss and improving metabolic health. [13] Thus, we aim to develop a novel exercise intervention (‘S&G exercise intervention’) that combines SE intervention with gamification and social incentives design through WeChat, with the aim of improving metabolic health and poor behaviors among overweight and obesity children. [14] Future diet intervention studies are clearly warranted to examine gut microbe-diet-host relationships to promote knowledge-based recommendations in relation to improving metabolic health in children. [15] These findings demonstrate that MFGM proteins contain potential bioactive ingredients for improving metabolic health. [16] The remarkable plasticity of mitochondria allows them to adjust their volume, structure, and capacity under conditions such as exercise, which is useful or improving metabolic health in individuals with various diseases and/or advancing age. [17] Conversely, improving metabolic health and obesity were associated with reduced CVD risk among initially metabolically unhealthy nonobese to secondary MHNO (aHR, 0. [18] WP administered after RT was more effective in improving metabolic health Z-score and in reducing body fat compared to placebo group. [19] Whilst there is limited evidence that simply prioritising energy intake to earlier in the day is an effective strategy for weight loss, we highlight the potential benefits of considering the role of meal timing for improving metabolic health and energy balance. [20] Further research is needed to explore social determinants of health and whether solutions outside the health sector could provide efficient means in preventing adverse pregnancy outcomes as well as improving metabolic health. [21] However, after adjusting for the larger absolute WL sustained, early and overall faster WLR do not appear to have advantages for improving metabolic health markers. [22] Conclusions Dietary modifications through decreasing fructose intake and addressing systemic endotoxemia are plausible targets for improving metabolic health of KTRs. [23] Beige fat serves as a substantial metabolic sink that dissipates energy and has consequently attracted much attention as a target for improving metabolic health. [24] Resistance training is essential for health and performance and confers many benefits such as increasing skeletal muscle mass, increasing strength and power output, and improving metabolic health. [25]nan [1] nan [2] nan [3] nan [4] nan [5] nan [6] nan [7] nan [8] nan [9] nan [10] nan [11] 목표 저탄수화물, 건강에 좋은 지방(LCHF) 식이 접근법은 대사 건강을 개선하기 위한 효과적인 전략으로 입증되었습니다. 그러나 국가 보건부의 영양 지침에 따른 식단 접근 방식을 따르는 것보다 비용이 많이 든다는 비판을 받는 경우가 많습니다. [12] 베이지색/갈색 지방으로 전환되는 백색 지방 갈변의 새로운 개념은 체중 감소 촉진 및 대사 건강 개선을 통한 항비만 효과에 대해 논란의 여지가 있습니다. [13] 따라서 우리는 과체중 및 비만 아동의 대사 건강 및 불량 행동을 개선하기 위해 WeChat을 통해 SE 개입과 게임화 및 사회적 인센티브 설계를 결합한 새로운 운동 개입('S&G 운동 개입')을 개발하는 것을 목표로 합니다. [14] 미래의 식이 중재 연구는 어린이의 대사 건강 개선과 관련하여 지식 기반 권장 사항을 촉진하기 위해 장내 미생물-식이 요법-숙주 관계를 조사하기 위해 분명히 보증됩니다. [15] 이러한 발견은 MFGM 단백질이 대사 건강을 개선하기 위한 잠재적인 생리 활성 성분을 함유하고 있음을 보여줍니다. [16] 미토콘드리아의 놀라운 가소성은 운동과 같은 조건에서 체적, 구조 및 능력을 조정할 수 있게 하여 다양한 질병 및/또는 노령화를 가진 개인의 대사 건강을 개선하거나 유용합니다. [17] 역으로, 대사 건강과 비만의 개선은 초기에 대사적으로 건강하지 않은 비비만에서 이차 MHNO(aHR, 0. [18] nan [19] nan [20] nan [21] nan [22] nan [23] nan [24] nan [25]
improving metabolic control 대사 조절 개선
Here, we evaluate the ability of SPX at improving metabolic control and liver function in obese and type 2 diabetic animals. [1] In the research, it has been revealed that improving metabolic control is an important factor because it reduces cardiovascular disease in T2DM. [2] Background: Type 2 Diabetes Mellitus (T2DM) affects many cognitive functions and aerobic plus resistance exercise training, named combined training (CT), by improving metabolic control may mitigate or reverse the cognitive impairment T2DM-related. [3] LINKING EVIDENCE TO ACTION New technology-based diabetes education has potential benefits for children and adolescents with T1DM, such as improving metabolic control through phone calls and increasing their self-efficacy of diabetes management. [4] In this context, bariatric surgery is one of the most effective treatment modalities in improving metabolic control. [5] Conclusion: This study explored the effectiveness of using the 5A model of self-management in improving metabolic control indicators in type 2 diabetic patients. [6] RESULTS K-means and two-step cluster analysis suggest a two-cluster solution providing information of distinct decision profiles (concerning multiple domains of risk-taking behavior) which almost perfectly match the biological partition, based on the division between stable or improving metabolic control (MC, N = 49) v. [7] This pilot study suggested that ILI in PLWH with prediabetes is feasible and effective in improving metabolic control, with its effects possibly modulated by sleep variability. [8] Conclusion: In youth with T2D sub-optimally controlled with current treatments, EQW was effective in improving metabolic control. [9] Conclusions: Our results suggested that the use of empagliflozin following a strict off-label protocol may represent an effective and safe option in real life among patients with T1D, improving metabolic control, and ameliorating some cardiovascular risk factors. [10] This study compared the effectiveness of RT and AT in improving metabolic control and protecting β‐cell function in people with prediabetes. [11] Discussion Glargine U300 is a good basal insulin alternative to treat T1DM, improving metabolic control in patients with HbA1c levels >7. [12] Conclusion: Improving metabolic control in patients with diabetes by the utilization of CRI-based GMs may have substantial positive effects on the expenditure of the healthcare systems of several European countries. [13] In many cases, it will instruct a personalized treatment regime, thus improving metabolic control. [14] Furthermore, the effectiveness of the empowerment-based interventions for improving metabolic control and diabetes knowledge are described. [15] Conclusion: Improving metabolic control and thus risk for comorbidities like MI by combining the glucose meter with CRI with telemedical features has the potential to reduce costs for European health care systems. [16]nan [1] nan [2] nan [3] nan [4] nan [5] nan [6] nan [7] nan [8] nan [9] 결론: 우리의 결과는 엄격한 오프 라벨 프로토콜에 따라 엠파글리플로진을 사용하는 것이 T1D 환자의 실생활에서 효과적이고 안전한 옵션을 나타낼 수 있고, 대사 조절을 개선하고, 일부 심혈관 위험 요인을 개선할 수 있음을 시사했습니다. [10] 이 연구는 당뇨병 전단계 환자에서 대사 조절을 개선하고 β-세포 기능을 보호하는 데 있어 RT와 AT의 효과를 비교했습니다. [11] 토론 Glargine U300은 HbA1c 수치가 >7인 환자의 대사 조절을 개선하는 T1DM 치료에 대한 좋은 기초 인슐린 대안입니다. [12] 결론: CRI 기반 GM을 활용하여 당뇨병 환자의 대사 조절을 개선하면 여러 유럽 국가의 의료 시스템 지출에 상당한 긍정적인 영향을 미칠 수 있습니다. [13] 많은 경우에 개인화된 치료 요법을 지시하여 대사 조절을 개선합니다. [14] nan [15] nan [16]
improving metabolic syndrome 대사증후군 개선
DPP-4 inhibitors and metformin showed favorable effects on improving metabolic syndrome by decreasing blood pressure, serum triglycerides (TG), low-density lipoprotein (LDL), total cholesterol, and increasing high-density lipoprotein (HDL), plus their positive impacts on weight. [1] Natural biological macromolecules with putative functions of gut microbiota regulation possess the advantage of improving metabolic syndrome (MS). [2] Discussion : Gastric bypass surgery and restrictive surgical treatments have been successful improving metabolic syndrome, insulin resistance and liver histology of obese patients. [3] The program may be effective in improving metabolic syndrome in obese children by promoting self-health management behaviors. [4] Baduanjin also plays an important role in improving metabolic syndrome through lifestyle intervention. [5] coelicolor A3(2) is a safe, non‐toxic substance, and therefore, can be used safely for manufacturing neoagarooligosaccharide, a functional substance effective in improving metabolic syndrome. [6] Therefore, MME is the potential candidate for improving metabolic syndrome and its related complications. [7] The microbiota abundance of the baicalin group was closer to that of the control group, increasing the population of SCFA-producing bacteria spp and improving metabolic syndrome, including abnormal glucose and lipid metabolism caused by a high-fat diet. [8] These observations suggest that improving metabolic syndrome is important to prevent type 2 diabetes, particularly for young adults. [9] lowering triglyceride and cholesterol levels reducing obesity and improving metabolic syndrome), while overcoming most of the adverse T3-dependent side effects. [10] Consequently, this study suggests the possibility of using EFAD for the prevention of neurodegeneration by improving metabolic syndrome that is caused by HFD. [11] However, the role of bGCR in improving metabolic syndrome (MetS) is not yet fully understood. [12] Bariatric surgery is the gold standard treatment for obesity; however, endoscopic approaches may have a significant role in improving metabolic syndrome and achieving weight loss. [13] Acetic acid, as a type of chemical compound, has been reported to be an emerging drug for improving metabolic syndrome and inhibiting inflammation in rats and human. [14]nan [1] nan [2] nan [3] nan [4] nan [5] coelicolor A3(2)는 안전한 무독성 물질로 대사증후군 개선에 효과적인 기능성 물질인 네오아가로올리고당 제조에 안전하게 사용할 수 있습니다. [6] 따라서 MME는 대사 증후군 및 관련 합병증을 개선할 수 있는 잠재적 후보입니다. [7] baicalin군의 미생물군은 대조군에 가까웠으며, SCFA를 생성하는 세균의 개체수가 증가하고 고지방 식이로 인한 비정상적인 포도당 및 지질 대사를 포함한 대사 증후군이 개선되었습니다. [8] 이러한 관찰은 특히 젊은 성인의 경우 제2형 당뇨병을 예방하기 위해 대사 증후군을 개선하는 것이 중요함을 시사합니다. [9] 트리글리세리드와 콜레스테롤 수치를 낮추는 것은 비만을 감소시키고 대사 증후군을 개선하는 동시에 대부분의 불리한 T3 의존성 부작용을 극복합니다. [10] 따라서 본 연구에서는 HFD로 인한 대사증후군을 개선하여 신경변성 예방에 EFAD의 활용 가능성을 제시하고 있다. [11] 그러나 대사 증후군(MetS) 개선에 있어서 bGCR의 역할은 아직 완전히 이해되지 않았습니다. [12] nan [13] nan [14]
improving metabolic parameter 대사 매개변수 개선
CONCLUSION Berberine has a substantial effect in improving metabolic parameters and modulating the gut microbiota composition in T2DM rats. [1] Dual-release hydrocortisone (DR-HC) resembles the daily normal cortisol profile improving metabolic parameters and quality of life. [2] Although there are little data thus far to support IGB therapy in the treatment of NASH, our case provides evidence of the potential benefit of IGB on improving metabolic parameters and markers of liver fibrosis. [3] Recent studies show that metformin not only improves chronic inflammation by improving metabolic parameters but also has a direct anti-inflammatory effect. [4] Conclusion Maintaining a healthy weight or achieving weight loss through Mediterranean diet pattern(3)and healthy lifestyle as suggested by WCRF may reduce breast cancer risk improving metabolic parameters (FIG1),especially those related to insulin resistance, moreover metabolic improvement can be maintained even after a slight weight regain. [5] We conclude that animal and plant protein similarly increase IGF-1 bioavailability while improving metabolic parameters and may be regarded as equivalent in this regard. [6] Conclusion The use of E2 alone, and not the individual use of P4, and its combination with E2 improved cardiovascular function in OVX diabetic animals, possibly by reducing the amount of inflammatory cytokines and improving metabolic parameters. [7] MgPic has a higher bioavailability and is more effective in improving metabolic parameters and enhancing memory than MgO. [8] Proper dietary management leads to weight loss are also effective in improving metabolic parameters in patients with both NAFLD and type 2 diabetes. [9] CONCLUSIONS Both LAGB and LAGBP demonstrated comparable efficacy in reducing body weight and improving metabolic parameters in a 24 to 36 mo follow-up period. [10] Thus, IDEP concept can be a promising treatment strategy, which positively influences the GLP‐1 levels and provide additive benefits in terms of improving metabolic parameters in patients with T2DM and slowing the progression of T2DM and its associated complications. [11] Glucagon-like peptide-1 analogue, sodium-dependent glucose cotransporter inhibitors, and peroxisome proliferator-activated receptor agonists have shown benefits in improving metabolic parameters and reducing hepatic lipid accumulation and inflammation. [12] Objective: Studies in experimental models of nonalcoholic fatty liver disease (NAFLD) have reported positive effects of soy components in improving metabolic parameters. [13] Improving metabolic parameters and lifestyle (diet and physical activity) should be reinforced. [14]nan [1] nan [2] nan [3] nan [4] nan [5] nan [6] nan [7] nan [8] nan [9] 결론 LAGB와 LAGBP는 모두 24~36개월의 추적 기간 동안 체중을 줄이고 대사 매개변수를 개선하는 데 필적할만한 효능을 보여주었습니다. [10] 따라서 IDEP 개념은 GLP-1 수준에 긍정적인 영향을 미치고 T2DM 환자의 대사 매개변수를 개선하고 T2DM 및 관련 합병증의 진행을 늦추는 측면에서 부가적인 이점을 제공하는 유망한 치료 전략이 될 수 있습니다. [11] 글루카곤 유사 펩티드-1 유사체, 나트륨 의존성 포도당 공동수송체 억제제 및 퍼옥시좀 증식제 활성화 수용체 작용제는 대사 매개변수를 개선하고 간 지질 축적 및 염증을 감소시키는 이점을 보여주었습니다. [12] nan [13] nan [14]
improving metabolic profile 대사 프로필 개선
SIRT1, SIRT3, and SIRT6 have been shown to provide protective effects in various cardiovascular disease models, by decreasing inflammation, improving metabolic profiles or scavenging oxidative stress. [1] SCOPE Dietary intervention to obese dams during pregnancy and lactation period provides avenues for improving metabolic profiles of the offspring. [2] GTC may be useful for improving metabolic profiles. [3] Thus, any intervention that immediately decreases adiposity and is relatively safe could be a viable method not only for aesthetic purpose but also for increasing the efficiency of insulin and improving metabolic profile, especially when combined with regular exercise and proper diet. [4] In this add-on pilot clinical investigation we received new data that L can inhibit proinflammatory NF-kB pathway by increased SIRT1 expression in obese patients with type 2 DM improving metabolic profile. [5] Supplementation of rumen-protected choline (RPC) has attracted major research efforts during the last decade, assuming that choline improves liver function by increasing very low-density lipoprotein exportation from the liver, thereby improving metabolic profiles, milk production, and reproduction. [6] 0318 preserved in our laboratory was orally administered to CTX-treated mice to explore its potential effects to attenuate the toxic effects of CTX-induced by modulating intestinal immune response, promoting intestinal integrity and improving metabolic profile. [7] Reduction in the circulating levels of branched-chain amino acids through dietary supplementation with α-ketoglutarate to promote their transamination in the small intestine and other tissues can restore nitric oxide synthesis in the vasculature and reduce the weights of white adipose tissues, thereby improving metabolic profiles and whole-body insulin sensitivity (indicated by oral glucose tolerance test) in diet-induced obese rats. [8] To investigate the efficacy and safety of a new-generation of NC in lowering BP values and improving metabolic profile, in a group of hyper-cholesterolemic subjects with pre-hypertension. [9]nan [1] nan [2] nan [3] nan [4] 이 추가 파일럿 임상 조사에서 우리는 L이 대사 프로필을 개선하는 2형 DM 비만 환자에서 SIRT1 발현을 증가시켜 전염증성 NF-kB 경로를 억제할 수 있다는 새로운 데이터를 받았습니다. [5]